We are live on
!
Find out more
JJ
Johnson & Johnson Portfolio holdings
AUM
$799M
1-Year Est. Return
253.51%
This Fund
S&P 500
This Quarter
Est. Return
+24.35%
1 Year Est. Return
+253.51%
3 Year Est. Return
+280.64%
5 Year Est. Return
+320.83%
10 Year Est. Return
–
AUM
$799M
AUM Growth
+$146M
(+22%)
Cap. Flow
+$11.1M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
98.41%
Holding
17
New
1
Increased
–
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBRS
Cerebras Systems
CBRS
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rallybio
RLYB
|
+$1.37M |
| 2 |
Nano X Imaging
NNOX
|
+$190K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.52% |
| 2 | Technology | 1.48% |
No holdings matched the selected filter criteria.
Similar funds
HP
ACM
AGA
IAM
UM
RIM
BCM
AI
Johnson & Johnson's Q2 2026 Portfolio in Review
As of Q2 2026, Johnson & Johnson held 17 positions worth $799M, up 22% from $652M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Johnson & Johnson's Q2 2026 filing shows 1 new and 2 closed positions. Its largest new stake was Cerebras Systems: 53,586 shares worth $11.8M. The largest sale was Rallybio, an estimated $1.37M.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Technology.
- Johnson & Johnson's largest Q2 2026 buy was Cerebras Systems: 53,586 shares worth $11.8M.
- Johnson & Johnson fully exited Rallybio in Q2 2026, selling an estimated $1.37M.
- Johnson & Johnson's ten largest holdings make up 98% of its $799M portfolio in Q2 2026.
- Johnson & Johnson opened 1 new position and closed 2 in Q2 2026.
- Johnson & Johnson's portfolio value rose 22% quarter-over-quarter to $799M.
Based on Johnson & Johnson's 13F filing for Q2 2026, filed 6 Aug 2026.